In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

bioMerieux, a Family-Owned French Firm, Finally Goes Public

Executive Summary

In early July, the family-owned French firm bioMerieux SA launched an IPO by listing a third of its shares on the French bourse. The offering has been a success, primarily enabling a restless shareholder to sell its stake. And while the microbiology company didn't raise money for itself, it will have to change its corporate culture, opening its books to the public for the first time and requiring it to be responsive to shareholders.
Advertisement

Related Content

Diagnostic Products Corp.: Thriving, For Now
Diagnostic Products Corp.: Thriving, For Now
How Big Can Bio-Rad Get?
How Big Can Bio-Rad Get?
A Tepid Wedding, Now A Possible Divorce
bioMerieux-Pierre Fabre Lives Up to Its Name
bioMerieux-Pierre Fabre Lives Up to Its Name
bioMerieux's and Pierre Fabre's Surprise
bioMerieux Pushes Ahead in Genomics
Focused Consolidator: bioMerieux

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002374

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel